Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuroNet-PHL-C1
NCT00433459Phase 3Completed
- Start
- Jan 2007
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dacarbazine in Classical Hodgkin Lymphoma (cHL). Started Jan 2007; status: completed.
02
Drugs
dacarbazine
03
Conditions
Classical Hodgkin Lymphoma (cHL)
Beyond the preview
Go deeper on NCT00433459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433459.